Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportEducational Exhibits - Oncology

Practical Guide to 177Lutetium PSMA Peptide Receptor Radionuclide Therapy for Prostate Cancer

Samuel Jang, Ayse Kendi, Brendan Lunn, Geoffrey Johnson and Ann Packard
Journal of Nuclear Medicine June 2023, 64 (supplement 1) P68;
Samuel Jang
1Mayo Clinic, Rochester, MN, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ayse Kendi
1Mayo Clinic, Rochester, MN, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brendan Lunn
2Mayo Clinic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Geoffrey Johnson
2Mayo Clinic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ann Packard
2Mayo Clinic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 64 no. supplement 1 P68

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online August 28, 2023.

Copyright & Usage 
© 2023

Author Information

  1. Samuel Jang,
  2. Ayse Kendi1,
  3. Brendan Lunn2,
  4. Geoffrey Johnson2 and
  5. Ann Packard2
  1. 1Mayo Clinic, Rochester, MN, USA
  2. 2Mayo Clinic

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: August 2023 to April 2025

AbstractFullPdf
Aug 2023300
Sep 20232300
Oct 20231800
Nov 20232500
Dec 20231400
Jan 20241300
Feb 20241100
Mar 20241200
Apr 20245100
May 20241300
Jun 20243400
Jul 202410200
Aug 202410700
Sep 20242700
Oct 20244100
Nov 20244800
Dec 20243500
Jan 20255400
Feb 20253300
Mar 20253500
Apr 202510000
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 64, Issue supplement 1
June 1, 2023
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Practical Guide to 177Lutetium PSMA Peptide Receptor Radionuclide Therapy for Prostate Cancer
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Practical Guide to 177Lutetium PSMA Peptide Receptor Radionuclide Therapy for Prostate Cancer
Samuel Jang, Ayse Kendi, Brendan Lunn, Geoffrey Johnson, Ann Packard
Journal of Nuclear Medicine Jun 2023, 64 (supplement 1) P68;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Practical Guide to 177Lutetium PSMA Peptide Receptor Radionuclide Therapy for Prostate Cancer
Samuel Jang, Ayse Kendi, Brendan Lunn, Geoffrey Johnson, Ann Packard
Journal of Nuclear Medicine Jun 2023, 64 (supplement 1) P68;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Advances in Therapeutic Managements in Lymphoma and the Role of FDG-PET/CT in Therapeutic Decision-Making
  • 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors: Review of Treatment Workflow and Challenging Clinical Scenarios
  • Positron Emission Tomography for Malignancy in Pregnancy
Show more Educational Exhibits - Oncology

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire